800
Participants
Start Date
August 31, 2005
Primary Completion Date
April 30, 2008
Study Completion Date
April 30, 2008
Fibrinogen (human) + thrombin (human) (TachoSil)
Intra-operatively treated patients with hemostatic supporting agents/techniques in addition to the standard surgical procedures
Nycomed, Roskilde
Lead Sponsor
Nycomed
INDUSTRY